A Study Evaluating Megestrol Acetate Modulation in Hormone Receptor Positive Advanced Breast Cancer

NCT03024580 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER_GOV

Sponsor class

Conditions

Breast Neoplasm

Interventions

DRUG: Megestrol Acetate 160Mg Tablet
DRUG: Anastrozole 1Mg Tablet
DRUG: Letrozole 2.5Mg Tablet
DRUG: Exemestane 25 MG
DRUG: Tamoxifen 20Mg Tablet
DRUG: Fulvestrant 50Mg Solution for Injection

Sponsor

Instituto Nacional de Cancer, Brazil

Collaborators

[object Object]